Search

Educational Services

Welcome to Educational Services! Department of Labs produced webinars are offered on the first Tuesday of every month covering disease specific and utilization management topics. Our webinars are PACE and ACCENT accredited. Contact Megan Hinch at MTS for more information: meganh@medtraining.org.

2017 Webinars

January

Tues 10

January 10th, 2017, 11am-12pm

Description of Program Content:

In this webinar, we will review the major causes of miscarriage, stillbirth, and neonatal death and provide information regarding the clinical utility of different types of genetic testing in these cases. In particular, we will discuss the most cost effective approach to comprehensive genetic testing aimed at providing answers for your patients who experience these heartbreaking losses.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Discuss the incidence and major causes of miscarriage, stillbirth, and neonatal death.
  • Describe the major genetic contributors to miscarriage, stillbirth, and neonatal death.
  • Explain the benefits and limitations of genetic testing in cases of miscarriage, stillbirth, and neonatal death.

Presenters:

Diane Allingham-Hawkins Ph.D, FCCMG, FACMG Laboratory Director at PreventionGenetics, LLC

Elizabeth McPherson MD Medical Genetics, Marshfield, WI

Mon 24

January 24, 2017, 11am-12pm

Description of Program Content:

The changes in healthcare are positioning laboratories to be more patient-centric by not only providing accurate diagnosis, but also reducing unnecessary testing to reduce costs. One proven solution is adopting an effective test utilization program to ensure the right test is delivered to the right patient at the right time. Erin Kaleta Ph.D., Clinical Director for General Laboratory and Toxicology, and Tamara Nelson, Lean Six Sigma Black Belt, will share how Sonora Quest Laboratories effectively implemented a test utilization management program to optimize quality care to patients and providers while increasing their bottom line.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Why proper test utilization is vital for quality patient care and sustainability for your lab.
  • How the right technology can simplify your lab operations with real-time analytics and provide efficiencies in staffing and supply ordering.
  • Proven methods on how test utilization improves reimbursement rates for prescription drug monitoring profiles.
  • How to use diagnostic algorithms to enhance provider-to-patient value through ordering recommendations.
  • Direct Access Testing (DAT) trends and demand to improve market tests and serve patients more effectively.

Presenters:

Erin Kaleta PhD Clinical Director for General Laboratory and Toxicology for Sonora Quest Laboratories and Laboratory Sciences of Arizona

Tamara Nelson M.S. Lean Master Black Belt at Sonora Quest Laboratories and Laboratory Sciences of Arizona

February

Tues 7

February 7th, 2017, 11am-12pm

Description of Program Content:

This webinar will provide guidance on informatics approaches to improving laboratory utilization. We will discuss proven approaches to analyzing laboratory data to better understand utilization patterns, strategies for engaging clinical partners, and laboratory information system plus laboratory workflow modifications that can improve utilization. Finally, we will describe general interventions in the electronic health record systems that can help sustain improved laboratory utilization.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Identify 3 variables that provide actionable information when analyzing laboratory utilization data.
  • Differentiate scenarios in which different types of stakeholder engagement are most effective.
  • Evaluate the feasibility of modifying your information systems to optimize laboratory ordering.

Presenter:

Patrick Mathias MD, Ph.D, University of Washington, Department of Laboratory Medicine

 

                         Brought to you by:

 Orchard Software

Tues 21

February 21st, 2017, 11am-12pm

Description of Program Content:

Traditional clinical genetic testing involved evaluating single variants or genes or, at most, a handful of genes using Sanger methods. Significant or potentially significant variants were confirmed. This was not an issue because there were so few to worry about. With the advent of highly parallel, genome-scale sequencing, the number of variants to confirm rose from a few to potentially hundreds or thousands. Laboratories and clinicians alike struggled with the urgent questions that arose: How many should be confirmed? What technology should be used to do it? This issue has become more prominent as some testing companies have dropped confirmation altogether while, at the other end of spectrum, others recoil at the thought of providing information that may include errors. The current dilemma is: Should we still confirm variants or is that simply a quaint notion that can be discarded as we move into the NGS era? We will discuss the various sequencing platforms and the potential risks and rewards of (skipping) confirmation.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Identify sources of error in different sequencing systems.
  • Understand sequence quality metrics.
  • Evaluate the cost and quality tradeoffs that are associated with confirming sequence variants.

Presenters:

John Thompson, Ph.D Chief Technology Officer at Claritas Genomics

March

Wed 8

March 8th, 2017, 11am-12pm

Description of Program Content:

This is the second of three in the Laboratory Stewardship series sponsored by Orchard Software in collaboration with Seattle Children’s Hospital.  In this episode of LabTalk our panel of experts takes on a variety of perplexing issues such as dealing with difficult administrators, effective approaches for considering new technology and trends, and mitigating quackery and hype.

Following the webinar, you will be able to:

    • Describe 3 techniques to align administrators and clinicians who may have competing priorities.
    • Identify 4 ways to discern real industry trends from quackery, hype and fads.
    • List 3 best practices that will help you overcome the most difficult human resources challenges in the lab.

About the speakers:

Moderator:

Mike Astion, MD, PhD, Medical Director, Department of Laboratories Seattle Children’s Hospital, Clinical Professor University of Washington Laboratory Medicine

Panelists:

Jim Hernandez, MD, MS, Associate Professor of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Medical Director of Laboratories Chair, Division of Laboratory Medicine. Jim is involved in the integration and standardization of the laboratories of the Mayo Clinic.  He also served as the Chairman of the Department of Laboratory Medicine's Clinical Practice Committee, which addresses lab utilization and he has instituted a leadership and management program for residents and fellows at Mayo Clinic.

Carmen Wiley PhD, is the Regional Manager of Scientific Affairs at Roche Diagnostics. She is responsible for leading and developing the Medical & Scientific Liaisons in their relationships with the medical/scientific community, with the objective of critical scientific exchange including medical/scientific education and responses to unsolicited “off label” inquiries.  She plays a key role in providing support to healthcare professionals as well as internal Roche scientific groups and local business teams. 

 

                      Brought to you by:

 Orchard Software

April

Tues 10

April 11th, 2017, 11am-12pm

Description of Program Content:

Genome/exome sequencing is often considered the DNA test of last resort. However, because genome sequencing cuts short many diagnostic odysseys and provides complete coverage of nearly all genes, genome sequencing should in many cases be the first test that is ordered. Genome sequencing helps to control costs and very often provides the best value to the patient. Dr. Weber will discuss applications of genome sequencing, the importance of an early and accurate diagnosis, and the cost advantages and limitations of genome sequencing.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Recite many of the applications of genomic sequencing.
  • Compare different genome sequencing tests.
  • Understand current limitations of genome sequencing
  • Gain a better appreciation for the value of genomic sequencing

Presenter:

James Weber, PhD Founder, President, and Chief Executive Officer, Prevention Genetics

May

Tues 16

May 16th, 2017, 12-1pm

Description of Program Content:

In this episode of Labtalk, national experts from GeneDx, University of Washington and Seattle Children’s Hospital will discuss current trends, current limitations and applications in rapid exome testing.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Discuss the applications of rapid exome testing.
  • Compare and analyze the nuances of rapid exome tests.
  • Understand current limitations of rapid exome testing.

About the speakers:

Moderator:

Mike Astion, MD, PhD, Medical Director, Department of Laboratories Seattle Children’s Hospital, Clinical Professor University of Washington Laboratory Medicine

Panelists:

James T. Bennett, MD, PhD, Genetics Medicine, Seattle Children's & UW Medicine

Jane Jasuula, PhD, FACMG, Director, Whole Exome Sequencing Program GeneDX

Robyn C. Reed, MD, Phd, Physician, Children's Minnesota

Sarah Clowes Candadai, Genetic Counselor, Seattle Children's Hospital

July

Tues 11

July 11th, 2017, 11am-12pm PT

Description of Program Content:

The webinar gives an overview of challenges that we still face today in next generation sequencing (NGS) based genetic diagnostics. These challenges are described also by using patient examples.  It also defines how these challenges should be taken into consideration when selecting the optimal diagnostic test. It then focuses on the concepts of transparency in genetic diagnostics and how the lack of transparency is one of the major problems in the field. Finally, it describes strategies how laboratories could improve their transparency and by that assisting the health care professionals in selecting the best test for their patients.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Understand the complexity and challenges associated with today’s NGS based genetic diagnostics
  • Describe features that should be considered when selecting the test for the patient
  • Understand the concepts of transparency in genetic diagnostics

Presenters:

Tero-Pekka Alastalo MD, PhD
Chief Medical Officer, Blueprint Genetics Inc

Tues 18

July 18th, 2017, 11am-12pm PT

Description of Program Content:

Laboratory test utilization often gets a bad reputation for being too prescriptive and overly focused on cost. The collaborative approach of the recent antimicrobial stewardship movement provides an effective model for addressing these negative elements in traditional laboratory utilization management efforts. Rebranding as laboratory stewardship and focusing on this same type of collaborative, relationship-based approach to interventions can be a valuable tool to help your laboratory reduce costs and the number of unnecessary tests being performed.
So how can your laboratory help ensure that clinicians order the most appropriate tests for their patients? Will providers be offended if you question their orders? And how do you manage providers who just want their tests performed, no questions asked?

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Create a provider attitude survey, including two of the most important topics you should include.
  • List three strategies for incorporating provider feedback into the development or modification of your laboratory’s stewardship program.

Presenters:

Jane Dickerson, PhD, DABCC
Co-director of Chemistry and Director of Reference Lab Services at Seattle Children’s Hospital

Jessie Conta, MS, LGC
Laboratory Genetic Counselor Supervisor, Seattle Children's Hospital

     Brought to you by:

 Orchard Software

 

Tues 25

July 25th, 2017, 11am-12pm PT

Description of Program Content:

Both coagulations tests and genetic tests can be effective diagnostic tools for bleeding disorders, but they are often misunderstood. We will discuss different testing strategies in coagulation testing and review testing algorithms that use complementary coagulation and genetic studies as a cost-effective and efficient means for establishing a diagnosis.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  • Discussion of the essential role of Genetic Counselors in test utilization management for coagulation disorders.
  • Describe algorithmic approaches for test selection, and examples of good vs. bad utilization management practices.
  • Discuss two case studies in Hemophilia A and von Willebrand disease (VWD).

Presenters:

Stephanie Dugan, MS, CGC
Genetic Counselor, BloodCenter of Wisconsin

 

Tues 15
"Test Utilization in the Clinical Laboratory"

August 15th, 2017, 11am-12pm PT

Description of Program Content:

The healthcare industry is shifting from a volume to value-based payment model, ushering in new economic incentives to drive patient, provider, and payer behaviors. This shift requires a new set of workflows dedicated to aligning resources and improving patient outcomes.

North Memorial Health Care, a Level 1 Trauma Care hospital located in Robbinsdale, MN, realized that adapting to the rapidly changing healthcare landscape meant implementing a test utilization program in its laboratory to achieve four main priorities: population health, patient quality experience, operational efficiency, and profitable growth. The program required the implementation of a healthcare CRM system to provide insight into data that previously would have been impossible to monitor.

With a proactive, CRM-led test utilization program in place, North Memorial Health saw:

  • A 50% reduction in high-cost, unreimbursed test ordering.
  • A 127% increase in Total T4 testing over T4 testing, a proven obsolete test.
  • A renewed focus on real-time customer insights, which saved a $150k relationship from attrition.

Join Patti Smith and Michele Koester, both in lab leadership at North Memorial Health, as they discuss how the lab successfully monitored obsolete and unproven test orders to directly impact physician ordering behaviors and patient outcomes.

Measurable Learning Objectives At the end of this activity the participant will be able to:

  1. Evaluate the use of diagnostic tests to deliver the right test to the right patient at the right time.
  2. Position the lab to become a strategic partner with physician clients.
  3. Encourage positive ordering behaviors to reduce unnecessary testing and underutilization of value tests.

 

Presenters:

Michele Koester
Medical Technologist and Core Lab Operations Supervisor, North Memorial Health Hospital

Patti Smith
Clinical Laboratory Scientist and Lab Manager, North Memorial Health Hospital